Boris Gilburd Selected Research

Autoimmune Diseases (Autoimmune Disease)

2/2021	Infusion of anti-DFS70 antibodies prolonged survival of lupus-prone mice.
7/2020	Algorithm for antinuclear antibodies in subjects with clinical suspicion of autoimmune diseases.
1/2020	Seroprevalences of autoantibodies and anti-infectious antibodies among Ghana's healthy population.
9/2018	Vimentin as antigenic target in autoimmunity: A comprehensive review.
7/2013	Evaluation of an automated chemiluminescent immunoassay kit for antinuclear antibodies in autoimmune diseases.
4/2012	Geographical differences in autoantibodies and anti-infectious agents antibodies among healthy adults.
3/2012	A novel automated indirect immunofluorescence autoantibody evaluation.
12/2008	Antioxidants and smoking in autoimmune disease--opposing sides of the seesaw?
6/2007	Early atherosclerosis and autoantibodies to heat-shock proteins and oxidized LDL in systemic sclerosis.
6/2007	Autoantibodies against protective molecules--C1q, C-reactive protein, serum amyloid P, mannose-binding lectin, and apolipoprotein A1: prevalence in systemic lupus erythematosus.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Boris Gilburd Research Topics

Disease

12	Autoimmune Diseases (Autoimmune Disease) 02/2021 - 12/2002
10	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2019 - 11/2002
10	Atherosclerosis 04/2008 - 01/2002
7	Infections 01/2021 - 06/2007
6	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 12/2020 - 12/2002
5	Glomerulonephritis 02/2021 - 08/2006
4	Proteinuria 05/2023 - 11/2002
4	Inflammation (Inflammations) 01/2023 - 01/2002
4	Rheumatoid Arthritis 09/2018 - 06/2005
4	Vasculitis (Vasculitides) 04/2012 - 04/2002
3	Rheumatic Diseases (Rheumatism) 07/2020 - 12/2014
3	Neoplasms (Cancer) 01/2019 - 03/2002
2	Ischemia 01/2023 - 01/2018
2	Necrosis 01/2023 - 01/2004
2	Lupus Nephritis 02/2021 - 08/2006
2	Autoimmune Diseases of the Nervous System 01/2021 - 01/2019
2	Memory Disorders (Memory Loss) 01/2021 - 11/2014
2	Thrombosis (Thrombus) 12/2020 - 01/2019
2	Hypertension (High Blood Pressure) 10/2018 - 06/2005
2	Ankylosing Spondylitis 10/2018 - 09/2018
2	Thrombophilia 04/2013 - 04/2012
2	Polymyositis 05/2012 - 03/2012
2	Systemic Scleroderma (Systemic Sclerosis) 03/2012 - 06/2007
2	Cardiovascular Diseases (Cardiovascular Disease) 04/2008 - 06/2005
1	Membranous Glomerulonephritis (Membranous Nephropathy) 05/2023
1	Reperfusion Injury 01/2023
1	Uveitis 09/2021
1	Anterior Uveitis 09/2021
1	Urologic Diseases (Urinary Tract Disease) 06/2021
1	Sleep Wake Disorders 01/2021
1	Fatigue 01/2021
1	Hyperprolactinemia 01/2021
1	Schizophrenia (Dementia Praecox) 01/2021
1	Autonomic Nervous System Diseases (Dysautonomia) 01/2021
1	Hearing Loss (Hearing Impairment) 01/2021
1	Cognitive Dysfunction 01/2021
1	Pain (Aches) 01/2021
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2020
1	Hemolytic Anemia 01/2019
1	Evans Syndrome 01/2019
1	Zika Virus Infection 01/2019
1	Ovarian Neoplasms (Ovarian Cancer) 01/2019
1	Pancytopenia 01/2019
1	Guillain-Barre Syndrome 01/2019
1	Multiple Sclerosis 12/2018
1	Atrophy 12/2018
1	Hyperaldosteronism (Conn Syndrome) 10/2018

Drug/Important Bio-Agent (IBA)

19	AntibodiesIBA 05/2023 - 03/2003
19	AutoantibodiesIBA 09/2021 - 03/2004
5	Phospholipids (Phosphatides)FDA LinkGeneric 09/2021 - 06/2007
5	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 09/2021 - 04/2002
5	Antinuclear AntibodiesIBA 07/2020 - 03/2004
5	oxidized low density lipoproteinIBA 09/2008 - 03/2003
4	Cardiolipins (Cardiolipin)IBA 09/2021 - 04/2008
4	Prothrombin (Factor II)IBA 09/2021 - 06/2007
4	Antiphospholipid AntibodiesIBA 09/2021 - 06/2005
4	Heat-Shock Proteins (Heat-Shock Protein)IBA 09/2008 - 10/2002
4	Intravenous Immunoglobulins (IVIG)FDA Link 03/2003 - 11/2002
3	AntigensIBA 09/2021 - 11/2014
3	Immunoglobulin G (IgG)IBA 02/2021 - 04/2013
3	EpitopesIBA 01/2020 - 04/2013
2	LeptinIBA 01/2023 - 01/2018
2	CytokinesIBA 01/2021 - 03/2006
2	N-Methylaspartate (NMDA)IBA 01/2021 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 09/2018
2	Immunoglobulins (Immunoglobulin)IBA 12/2018 - 12/2002
2	Matrix Metalloproteinases (MMPs)IBA 09/2018 - 11/2002
2	Rheumatoid FactorIBA 12/2014 - 06/2005
2	anti-dsDNA autoantibodyIBA 11/2014 - 08/2006
2	C-Reactive ProteinIBA 04/2011 - 06/2007
2	DNA (Deoxyribonucleic Acid)IBA 08/2006 - 11/2002
1	Biomarkers (Surrogate Marker)IBA 05/2023
1	Serum AlbuminIBA 05/2023
1	Interleukin-6 (Interleukin 6)IBA 01/2023
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 09/2021
1	PhosphatidylserinesIBA 09/2021
1	Botulinum Toxins (Botulinum Toxin)IBA 06/2021
1	Antigen-Antibody Complex (Immune Complex)IBA 02/2021
1	Phosphates (Orthophosphate)IBA 02/2021
1	SiliconesIBA 01/2021
1	AcidsIBA 01/2021
1	Antipsychotic Agents (Antipsychotics)IBA 01/2021
1	gamma-Aminobutyric Acid (GABA)IBA 01/2021
1	Type 1 Angiotensin ReceptorIBA 01/2021
1	Endothelin Receptors (Endothelin Receptor)IBA 01/2021
1	ChemokinesIBA 01/2021
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2021
1	KynurenineIBA 01/2021
1	APTIBA 12/2020
1	amphiphysinIBA 01/2019
1	Bortezomib (Velcade)FDA Link 01/2019
1	Surface Antigens (Surface Antigen)IBA 01/2019
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 01/2019
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 01/2019
1	HLA-DRB1 Chains (HLA DRB1)IBA 01/2019
1	ReninIBA 10/2018
1	AldosteroneIBA 10/2018

Therapy/Procedure

2	Oral Administration 06/2004 - 12/2002
1	Breast Implants (Breast Implant) 01/2021
1	Plasma Exchange 01/2019